Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin for secondary prevention after myocardial infarction or unstable angina
ACTRN12616000535471Phase 3Completed
- Sponsor
- University of Sydney
- Start
- Mar 1990
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Pravastatin with Placebo (2 arms). Primary endpoint: Mortality due to coronary heart disease. Started Mar 1990; status: completed.
02
Drugs
pravastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12616000535471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000535471.